VYRIX PHARMACEUTICALS, INC. FORM OF [DIRECTOR][OFFICER] INDEMNIFICATION AGREEMENTIndemnification Agreement • May 7th, 2014 • Vyrix Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of by and between Vyrix Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • April 16th, 2014 • Vyrix Pharmaceuticals, Inc. • Pharmaceutical preparations • Colorado
This Amended and Restated Employment Agreement (the “Agreement”), is entered into as of March 11, 2014 (the “Effective Date”) between Vyrix Pharmaceuticals, Inc., a Delaware corporation (hereinafter referred to as the “Company”), and Jarrett Disbrow (“Employee”).
Text Omitted and Filed Separately with the Securities and Exchange Commission DISTRIBUTION AND LICENSE AGREEMENTDistribution and License Agreement • April 16th, 2014 • Vyrix Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Text Omitted and Filed Separately with the Securities and Exchange Commission DISTRIBUTION AGREEMENT DATED AS OF MARCH 1, 2012 BETWEEN AMPIO PHARMACEUTICALS, INC. AND FBM INDUSTRIA FARMACEUTICA, LTDA.Distribution Agreement • April 16th, 2014 • Vyrix Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
DISTRIBUTION AGREEMENT (this “Agreement”), dated as of March 1, 2012 (the “Effective Date”), between Ampio Pharmaceuticals, Inc., a Delaware corporation (“Ampio”), and FBM Industria Farmaceutica, Ltda., VP 3D, Qd, 8B, Mod. 9112 CEP 75132-095, Anapolis - GO, Brazil (“Distributor”). Each of Ampio and Distributor are referred to herein as a “Party” or the “Parties.”
INTERCOMPANY LOAN AGREEMENTIntercompany Loan Agreement • May 7th, 2014 • Vyrix Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
INTERCOMPANY LOAN AGREEMENT (this “Agreement”), dated as of November 18, 2013, by and between Ampio Pharmaceuticals, Inc., a Delaware corporation (“Lender”), and Vyrix Pharmaceuticals, Inc., a Delaware corporation (“Borrower”), a wholly-owned subsidiary of Lender.
ASSIGNMENT OF INTELLECTUAL PROPERTYAssignment of Intellectual Property • March 12th, 2014 • Vyrix Pharmaceuticals, Inc. • Pharmaceutical preparations
This Assignment of Intellectual Property (this “Assignment’) is effective as of this 3rd day of December 2013 (the “Effective Date”), by and between Ampio Pharmaceuticals, Inc., a Delaware Corporation (“Assignor”), and Vyrix Pharmaceuticals, Inc., a Delaware Corporation (“Assignee”). Each of Assignor and Assignee shall be referred to herein as a “Party” and, together, as the “Parties”.
SERVICES AGREEMENTServices Agreement • April 16th, 2014 • Vyrix Pharmaceuticals, Inc. • Pharmaceutical preparations • Colorado
THIS AGREEMENT is made as of January 1, 2014 (the “Effective Date”) between Ampio Pharmaceuticals, Inc., a Delaware corporation (“Parent”), and Vyrix Pharmaceuticals, Inc., a Delaware corporation (“Subsidiary”).
ASSIGNMENT AND ASSUMPTION AGREEMENTAssignment and Assumption Agreement • April 16th, 2014 • Vyrix Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This ASSIGNMENT AND ASSUMPTION AGREEMENT (this “Assignment”) is dated as of December 1, 2013, by and between Ampio Pharmaceuticals, Inc., a Delaware corporation (“Assignor”), and Vyrix Pharmaceuticals, Inc., a Delaware corporation (“Assignee”), a wholly-owned subsidiary of Assignor.
CONSULTING AGREEMENTConsulting Agreement • May 7th, 2014 • Vyrix Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT is made and entered into as of March 11, 2014 ( “Effective Date”) by and between Vyrix Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Dr. Vaughan L. Clift, an individual (“Consultant”). The Company and the Consultant are each a “Party” and collectively the “Parties”.
